DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» MERTK
MERTK
Download
LY2801653 Is an Orally Bioavailable Multi-Kinase Inhibitor with Potent
Crystal Structure of the Kinase Domain of Mertk in Complex with AZD7762 Provides Clues for Structure-Based Drug Development
MERTK Antibody Catalog Number: MKT-101AP Lot Number: General Information
Diverse, Biologically Relevant, and Targetable Gene Rearrangements in Triple-Negative Breast Cancer and Other Malignancies Timothy M
Mertk Regulates Thymic Selection of Autoreactive T Cells
Mertk Inhibition Is a Novel Therapeutic Approach for Glioblastoma Multiforme
A High-Throughput Integrated Microfluidics Method Enables
The Receptor Tyrosine Kinase Mertk Activates Phospholipase C γ
Pathogenicity Control That Serve As Mda5 Ligands, in Addition to Editing Other RNA Targets
Mertk: a Novel Target in Non-Small Cell Lung Cancer
Enhanced Expression of Receptor Tyrosine Kinase Mer (MERTK) on SOCS3-Treated Polarized RAW 264.7 Anti-Inflammatory M2c Macrophages
Kinome Expression Profiling to Target New Therapeutic Avenues in Multiple Myeloma
Functional Screen Identifies Kinases Driving Prostate Cancer Visceral and Bone Metastasis
Targeting Tyro3, Axl and Mertk (TAM Receptors): Implications for Macrophages in the Tumor Microenvironment Kayla V
Conventional Dendritic Cells Impair Recovery After Myocardial Infarction
Kinome Profiling of Non-Hodgkin Lymphoma Identifies Tyro3 As a Therapeutic Target in Primary Effusion Lymphoma
Chromosomal Abnormalities in Hepatic Cysts Point to Novel Polycystic Liver Disease Genes
Top View
Receptor Kinase Profiles Identify a Rationale for Multitarget Kinase
The Proto-Oncogene Mer Tyrosine Kinase Is a Novel Therapeutic Target
(TYRO3, AXL, MER) Family Small-Molecule Kinase Inhibitor Yumi Yokoyama1, Erin D
MER / MERTK Antibody (C-Terminus) Goat Polyclonal Antibody Catalog # ALS13420
Phagocytosis of Apoptotic Cells Required for Mer Tyrosine Kinase
Immune Cell Guide
RTK25: a Comprehensive Molecular Profiling Strategy In
Receptor Ectodomain Shedding in Treatment, Resistance, and Monitoring of Cancer
Rabbit Anti-MERTK/FITC Conjugated Antibody-SL23695R-FITC
TAM Receptor Tyrosine Kinases in Cancer Drug Resistance Mikaella Vouri and Sassan Hafizi
MET Exon 14 Skipping Alterations in Non-Small Cell Lung Carcinoma—Current Understanding and Therapeutic Advances
Mertk Antibody [Clone TPKR-1] (V8001)
Autocrine Signaling by Receptor Tyrosine Kinases in Urothelial Carcinoma of the Bladder
Targeting Receptor Kinases in Colorectal Cancer
Anti-MERTK Antibody (ARG10784)
S41467-020-15428-0.Pdf
Membrane Receptor Mertk Is a Newly Identified Transcriptional Regulator
Plasma Receptor Tyrosine Kinase RET in Pulmonary Arterial Hypertension Diagnosis and Differentiation
Cluster of Differentiation Antigen 135; CD135; Fms Like Tyrosine Kinase 3
Triple Therapy with Mertk and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses Mauricio S
Discovery of Small Molecule Mer Kinase Inhibitors for the Treatment
Polarization and Mertk Induction by Human Macrophages Requires
MERTK Antibody
Elucidation of the Signaling Pathway of MERTK
AXL Receptor Tyrosine Kinase As a Therapeutic Target in Hematological Malignancies: Focus on Multiple Myeloma
CD135;Fms Like Tyrosine Kinase 3
Kinase Targeting Therapies in Chronic Lymphocytic Leukemia: Mechanisms of Acquired Ibrutinib Resistance and the Pre-Clinical Development of OSU-T315
Protein Tyrosine Kinase/RTK
MERTK Receptor Tyrosine Kinase Is a Therapeutic Target in Melanoma Jennifer Schlegel,1 Maria J
Recent Advances in Kinase Drug Discovery Part I: the Editors' Take
Mertk Is a Functional Regulator of Myelin Phagocytosis by Human Myeloid Cells Luke M
Schwann Cells Use TAM Receptor-Mediated Phagocytosis In
Molecular Pathways: MERTK Signaling in Cancer
Eruptive Spitz Nevus, a Striking Example of Benign Metastasis Shyam S
MERTK Inhibition Alters the PD-1 Axis and Promotes Anti- Leukemia Immunity
Natural Killer Cell Differentiation Driven by Tyro3 Receptor Tyrosine Kinases
7/28/2021 Human MERTK / Mer Protein, Fc Tag Catalog # MEK-H5253
Receptor Tyrosine Kinase
MERTK Inhibition: Potential As a Treatment Strategy in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer
Role of Tyrosine Kinase Receptor Mertk in Innate and Adaptive Immune Response
Cshperspect-RTK-A009076 1..17
Immunoreceptor Mertk: a Journey from the Membrane Into the Nucleus of Human Dendritic Cells
1 Mononuclear Phagocytes Drive Mertk-Dependent T Cell Regulation
Pyrimidine Nucleoside Kinase Uck1 and Tam Receptor Tyrosine
Identification of the Signalosome and Signaling Pathway of the Efferocytic Receptor MERTK" (2020)
Exploring the Use of Tyrosine Kinase Inhibitors in Glioblastoma